Evidence map›Paper›PMID 15243106›Full record

ArticleJournal of clinical microbiology2004

Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis.

Parissa Farnia, Foroazan Mohammadi, Mehdi Mirsaedi, Abolhasan Zia Zarife, Javad Tabatabee, Katayoon Bahadori, Muslem Bahadori, Mohammad Reza Masjedi, Ali Akbar Velayati

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Mutations inAntimicrobial agents and chemotherapy · 2020
    Article
  2. Review
  3. Article
  4. Diagnosis & treatment of tuberculosis in HIV co-infected patients.The Indian journal of medical research · 2011
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Parissa FarniaIranian National Reference TB Laboratory, National Research Institute of Tuberculosis and Lung Disease, Shaheed Beheshti University of Medical Sciences & Health Services, Darabad, Tehran 19556, Iran. pfarnia@hotmail.com
Foroazan Mohammadi
Mehdi Mirsaedi
Abolhasan Zia Zarife
Javad Tabatabee
Katayoon Bahadori
Muslem Bahadori
Mohammad Reza Masjedi
Ali Akbar Velayati
Masih Daneshvari Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By oxidation-reduction assay, the viability of Mycobacterium tuberculosis in sputum specimens was evaluated. The technique is based on the Alamar Blue and Malachite Green dyes, which change their color in response to M. tuberculosis growth. The method is simple, permits visual reading of results, and is applicable for laboratories with limited resources.

Indexed as

OxazinesXanthenesColorColoring AgentsCulture MediaHumansMycobacterium tuberculosisOxidation-ReductionRosaniline DyesSputumTuberculosis, PulmonaryColoring AgentsCulture Mediamalachite greenOxazinesresazurinRosaniline DyesXanthenes

Identifiers

PMID15243106
PMCPMC446278
OpenAlexW1998372495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.